140 related articles for article (PubMed ID: 36162158)
1. Oncocytic nodular hyperplasia of the thyroid.
Suster D; Ronen N; Giorgadze T
Ann Diagn Pathol; 2022 Dec; 61():152049. PubMed ID: 36162158
[TBL] [Abstract][Full Text] [Related]
2. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
3. Cytologic Diagnosis of Oncocytic Neoplasms of the Thyroid Gland: The Importance of the Clinical Scenario.
Straccia P; Santeusanio G; Pierconti F; Brunelli C; Fadda G
Appl Immunohistochem Mol Morphol; 2019; 27(10):726-731. PubMed ID: 30358610
[TBL] [Abstract][Full Text] [Related]
4. Defective ciliogenesis in thyroid hürthle cell tumors is associated with increased autophagy.
Lee J; Yi S; Kang YE; Chang JY; Kim JT; Sul HJ; Kim JO; Kim JM; Kim J; Porcelli AM; Kim KS; Shong M
Oncotarget; 2016 Nov; 7(48):79117-79130. PubMed ID: 27816963
[TBL] [Abstract][Full Text] [Related]
5. Possible association of CEA expression with oxyphilic change but not with C-cell hyperplasia in Hashimoto's thyroiditis.
Gakiopoulou H; Litsiou E; Valaris K; Balafoutas D; Patsouris E; Tseleni-Balafouta S
Endocr J; 2010; 57(8):693-9. PubMed ID: 20616436
[TBL] [Abstract][Full Text] [Related]
6. The oncocytic variant of papillary carcinoma of the thyroid: a clinicopathologic study of 15 cases.
Berho M; Suster S
Hum Pathol; 1997 Jan; 28(1):47-53. PubMed ID: 9013831
[TBL] [Abstract][Full Text] [Related]
7. Hashimoto's thyroiditis associated with thyroid adenoma with Hürthle cells - case report.
Stanciu M; Bera LG; Popescu M; Grosu F; Popa FL
Rom J Morphol Embryol; 2017; 58(1):241-248. PubMed ID: 28523326
[TBL] [Abstract][Full Text] [Related]
8. Thyroid Oncocytic (Hürthle Cell) Nodules With Longitudinal Nuclear Grooves: Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of 15 Cases.
Suster D; Mackinnon AC; Suster S
Arch Pathol Lab Med; 2023 Jun; 147(6):684-691. PubMed ID: 36084253
[TBL] [Abstract][Full Text] [Related]
9. Malignancy risk in indeterminate thyroid nodules with Hürthle cells: role of autoimmune thyroiditis.
Perticone F; Maggiore R; Mari G; Frara S; Baldassarre P; Doglioni C; Lena MS; Rosati R; Lanzi R; Giustina A
Endocrine; 2022 Mar; 75(3):823-828. PubMed ID: 34755316
[TBL] [Abstract][Full Text] [Related]
10. Oncocytic Change in Thyroid Pathology.
Asa SL; Mete O
Front Endocrinol (Lausanne); 2021; 12():678119. PubMed ID: 34012422
[TBL] [Abstract][Full Text] [Related]
11. Psammomatous calcifications in thyroid oncocytic (Hürthle cell) follicular tumors.
Ronen N; Suster D
Ann Diagn Pathol; 2023 Feb; 62():152061. PubMed ID: 36459776
[TBL] [Abstract][Full Text] [Related]
12. Malignancy risk for solitary and multiple nodules in Hürthle cell-predominant thyroid fine-needle aspirations: A multi-institutional study.
Wong KS; Jo VY; Lowe AC; Faquin WC; Renshaw AA; Shah AA; Roh MH; Stelow EB; Krane JF
Cancer Cytopathol; 2020 Jan; 128(1):68-75. PubMed ID: 31751003
[TBL] [Abstract][Full Text] [Related]
13. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
[TBL] [Abstract][Full Text] [Related]
14. Poorly differentiated oncocytic (hürthle cell) follicular carcinoma: an institutional experience.
Bai S; Baloch ZW; Samulski TD; Montone KT; LiVolsi VA
Endocr Pathol; 2015 May; 26(2):164-9. PubMed ID: 25898815
[TBL] [Abstract][Full Text] [Related]
15. Shear wave elastography in the diagnosis of thyroid nodules: feasibility in the case of coexistent chronic autoimmune Hashimoto's thyroiditis.
Magri F; Chytiris S; Capelli V; Alessi S; Nalon E; Rotondi M; Cassibba S; Calliada F; Chiovato L
Clin Endocrinol (Oxf); 2012 Jan; 76(1):137-41. PubMed ID: 21740455
[TBL] [Abstract][Full Text] [Related]
16. Fine-needle aspiration biopsy specimen with a predominance of Hürthle cells: a dilemma in the management of nodular thyroid disease.
Alaedeen DI; Khiyami A; McHenry CR
Surgery; 2005 Oct; 138(4):650-6; discussion 656-7. PubMed ID: 16269293
[TBL] [Abstract][Full Text] [Related]
17. Oncocytic variant of papillary thyroid carcinoma associated with Hashimoto's thyroiditis: a case report and review of the literature.
Lee J; Hasteh F
Diagn Cytopathol; 2009 Aug; 37(8):600-6. PubMed ID: 19526577
[TBL] [Abstract][Full Text] [Related]
18. Can abundant colloid exclude oncocytic (Hürthle cell) carcinoma in thyroid fine needle aspiration? Cytohistological correlation of 127 oncocytic (Hürthle cell) lesions.
Yang GC; Schreiner AM; Sun W
Cytopathology; 2013 Jun; 24(3):185-93. PubMed ID: 22672530
[TBL] [Abstract][Full Text] [Related]
19. An immunohistochemical study of thyroid Hurthle cells and their neoplasms: the roles of S-100 and HMB-45 proteins.
Abu-Alfa AK; Straus FH; Montag AG
Mod Pathol; 1994 Jun; 7(5):529-32. PubMed ID: 7937716
[TBL] [Abstract][Full Text] [Related]
20. The thyroid Hürthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review.
Montone KT; Baloch ZW; LiVolsi VA
Arch Pathol Lab Med; 2008 Aug; 132(8):1241-50. PubMed ID: 18684023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
